Zentiva Pharma has recalled the batch of Co-codamol 30/500 effervescent tablets as a precautionary measure due to an “issue with the homogeneity of the batch”.
The company said some of the medicines were found to have “too little active ingredients (codeine phosphate and paracetamol) in them”, while “some may contain too much active ingredients”.
As per the current investigation, the tablets were identified where the content of both codeine and paracetamol was less than the label claimed.
The medicine with batch number 1K10121 was distributed first in the month of March this year.
|Batch Number||Expiry Date||Pack Size||First Distributed|
|1K10121||December 2023||100||March 2021|
With this potential risk to the patients, the regulators advised that healthcare professionals immediately stop supplying the said batch of the medicine and “quarantine all remaining stock” and “return the said batch of tablets to their supplier”. The regulators also suggested to contact all patients who have been dispensed the impacted batch and have asked them to “urgently return the stock to the pharmacy for replacement.”